News and Trends 16 Jun 2022
Spirea raises £2.4M to develop antibody drug conjugates in cancer
…a wide range of cancers.” Better efficacy and safety Spirea’s technology allows more cytotoxic drug to be attached to the targeting antibody (a higher drug-to-antibody ratio), which means more drug…
